Chart calendar ARS Pharmaceuticals, Inc.

b14c84c4.xw1uOXpv-hfWZhSh7PkffXp4Oj_e1wCP4pjV0Z2blSc.k0YkXhxWrFC0Xnf2v7csSTtJUX2ftC3Cq-Kt5vr1-VLxewhDDFy-VptUYw~38a80cb2b0dbc763f8cc12eb15001158

Upcoming events on ARS Pharmaceuticals, Inc.

25/06/2025 17:00 Annual General Meeting
05/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)
18/03/2026 Q4 2025 Earnings Release (Projected)
18/05/2026 Q1 2026 Earnings Release (Projected)

Past events on ARS Pharmaceuticals, Inc.

04/06/2025 22:30 Jefferies Healthcare Conference
03/06/2025 17:20 William Blair Growth Stock Conference
14/05/2025 13:30 Q1 2025 Earnings Call
14/05/2025 12:00 Q1 2025 Earnings Release
20/03/2025 12:30 Q4 2024 Earnings Call
20/03/2025 11:00 Q4 2024 Earnings Release
15/03/2025 Roth Conference
10/03/2025 18:20 Leerink Partners Global Healthcare Conference
01/03/2025 22:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma and Immunology Scientific Meeting - Poster ID No. 318
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma and Immunology Scientific Meeting - Poster ID No. 290
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
01/03/2025 17:45 American Academy of Allergy, Asthma & Immunology World Allergy Organization Joint Congress - Poster
28/02/2025 02:30 Non-CME Corporate Forum
12/02/2025 19:40 Oppenheimer Healthcare Life Sciences Conference
15/01/2025 15:30 JP Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
1,32
1,27
3.89%
0,03
0,01
200%
89,1
18,5
382.41%

74,8


198


347

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-35,5
-76,8
53.78%
-67,5
-76,2
11.36%
-3,08
-61,9
95.02%

-158


-80,4


26,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-34,7
-74,8
53.65%
-54,4
-63,6
14.53%
8,29
-69,8
111.88%

-149


-73,9


32,1

Net income
Million USD
Released
Forecast
Spread
-34,7
-73,2
52.63%
-54,4
-60,8
10.58%
8,00
-55,8
114.33%

-149


-73,2


28,2

EPS
USD
Released
Forecast
Spread
-0,87
-1,33
34.34%
-0,57
-0,64
10.94%
0,08
-0,58
113.75%

-1,51


-0,73


0,22

Announcement Date23/03/2321/03/2420/03/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,50
0,67
-25%
2,07
0,58
259.65%
86,6
15,9
444.53%
7,97
7,48
6.57%

12,9


26,9


27,3


22,5


45,6


79,8


55,8

EBIT
Million USD
Released
Forecast
Spread
-18,0
-21,0
14.34%
-10,2
-17,5
41.41%
-13,2
-10,2
-28.99%
-15,3
-12,3
-25.12%
-21,7
-20,1
-7.95%
47,2
-13,7
444.54%
-37,2
-35,3
-5.3%

-48,4


-45,0


-27,7


-40,5


-42,3


-20,0


-56,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,9
-18,8
20.71%
-7,17
-15,0
52.25%
-10,3
-7,49
-37.48%
-12,5
-9,52
-31.46%
-19,1
-17,7
-8.15%
50,2
-24,1
308.01%
-33,9
-33,2
-2.32%

-46,8


-43,5


-26,2


-38,7


-40,8


-18,8


-55,0

Net income
Million USD
Released
Forecast
Spread
-14,9
-17,5
15.21%
-7,17
-13,6
47.33%
-10,3
-10,4
1.45%
-12,5
-11,6
-7.77%
-19,1
-17,2
-11.05%
49,9
-14,4
446.35%
-33,9
-35,1
3.33%

-46,0


-44,0


-25,9


-38,7


-40,8


-18,8


-55,0

EPS
USD
Released
Forecast
Spread
-0,16
-0,18
12.73%
-0,07
-0,14
50%
-0,11
-0,11
0%
-0,13
-0,11
-18.18%
-0,20
-0,15
-35.59%
0,51
-0,14
464.29%
-0,35
-0,35
-0.96%

-0,48


-0,43


-0,26


-0,35


-0,31


-0,11


-0,16

Announcement Date09/11/2321/03/2409/05/2406/08/2413/11/2420/03/2514/05/25-------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. Calendar ARS Pharmaceuticals, Inc.